Systemic itraconazole in the yellow nail syndrome

Antonella Tosti, B. M. Piraccini, M. Iorizzo

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Although a number of treatments have been reported to be effective with yellow nail syndrome (YNS), vitamin E at high doses is the only one that has been successfully utilized in a consistent number of patients affected by YNS. Recent data indicate that itraconazole pulse regimen may be effective in this disease. We report our experience with itraconazole treatment in patients affected by YNS. Systemic itraconazole was administered in eight patients (five males and three females; mean age 55.2 years), at a dosage of 400 mg daily for 1 week a month for 6 months. Nail growth was measured every 3 months. Complete cure was achieved in two of eight patients, with mild improvement in two and no improvement in four. The results of our study show that itraconazole cannot be considered effective for YNS, especially if compared with vitamin E, the efficacy and tolerability of which is already proven.

Original languageEnglish
Pages (from-to)1064-1067
Number of pages4
JournalBritish Journal of Dermatology
Volume146
Issue number6
DOIs
StatePublished - Jul 27 2002
Externally publishedYes

Fingerprint

Yellow Nail Syndrome
Itraconazole
Vitamin E
Nails
Therapeutics
Growth

Keywords

  • Antifungals
  • Nail growth
  • Onychodystrophy
  • Vitamin E

ASJC Scopus subject areas

  • Dermatology

Cite this

Systemic itraconazole in the yellow nail syndrome. / Tosti, Antonella; Piraccini, B. M.; Iorizzo, M.

In: British Journal of Dermatology, Vol. 146, No. 6, 27.07.2002, p. 1064-1067.

Research output: Contribution to journalArticle

Tosti, Antonella ; Piraccini, B. M. ; Iorizzo, M. / Systemic itraconazole in the yellow nail syndrome. In: British Journal of Dermatology. 2002 ; Vol. 146, No. 6. pp. 1064-1067.
@article{5ddd3ba3f896466c975573123ca6d79a,
title = "Systemic itraconazole in the yellow nail syndrome",
abstract = "Although a number of treatments have been reported to be effective with yellow nail syndrome (YNS), vitamin E at high doses is the only one that has been successfully utilized in a consistent number of patients affected by YNS. Recent data indicate that itraconazole pulse regimen may be effective in this disease. We report our experience with itraconazole treatment in patients affected by YNS. Systemic itraconazole was administered in eight patients (five males and three females; mean age 55.2 years), at a dosage of 400 mg daily for 1 week a month for 6 months. Nail growth was measured every 3 months. Complete cure was achieved in two of eight patients, with mild improvement in two and no improvement in four. The results of our study show that itraconazole cannot be considered effective for YNS, especially if compared with vitamin E, the efficacy and tolerability of which is already proven.",
keywords = "Antifungals, Nail growth, Onychodystrophy, Vitamin E",
author = "Antonella Tosti and Piraccini, {B. M.} and M. Iorizzo",
year = "2002",
month = "7",
day = "27",
doi = "10.1046/j.1365-2133.2002.04671.x",
language = "English",
volume = "146",
pages = "1064--1067",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Systemic itraconazole in the yellow nail syndrome

AU - Tosti, Antonella

AU - Piraccini, B. M.

AU - Iorizzo, M.

PY - 2002/7/27

Y1 - 2002/7/27

N2 - Although a number of treatments have been reported to be effective with yellow nail syndrome (YNS), vitamin E at high doses is the only one that has been successfully utilized in a consistent number of patients affected by YNS. Recent data indicate that itraconazole pulse regimen may be effective in this disease. We report our experience with itraconazole treatment in patients affected by YNS. Systemic itraconazole was administered in eight patients (five males and three females; mean age 55.2 years), at a dosage of 400 mg daily for 1 week a month for 6 months. Nail growth was measured every 3 months. Complete cure was achieved in two of eight patients, with mild improvement in two and no improvement in four. The results of our study show that itraconazole cannot be considered effective for YNS, especially if compared with vitamin E, the efficacy and tolerability of which is already proven.

AB - Although a number of treatments have been reported to be effective with yellow nail syndrome (YNS), vitamin E at high doses is the only one that has been successfully utilized in a consistent number of patients affected by YNS. Recent data indicate that itraconazole pulse regimen may be effective in this disease. We report our experience with itraconazole treatment in patients affected by YNS. Systemic itraconazole was administered in eight patients (five males and three females; mean age 55.2 years), at a dosage of 400 mg daily for 1 week a month for 6 months. Nail growth was measured every 3 months. Complete cure was achieved in two of eight patients, with mild improvement in two and no improvement in four. The results of our study show that itraconazole cannot be considered effective for YNS, especially if compared with vitamin E, the efficacy and tolerability of which is already proven.

KW - Antifungals

KW - Nail growth

KW - Onychodystrophy

KW - Vitamin E

UR - http://www.scopus.com/inward/record.url?scp=0036068970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036068970&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2133.2002.04671.x

DO - 10.1046/j.1365-2133.2002.04671.x

M3 - Article

VL - 146

SP - 1064

EP - 1067

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 6

ER -